483 related articles for article (PubMed ID: 32881214)
1. Natural products as home-based prophylactic and symptom management agents in the setting of COVID-19.
Thota SM; Balan V; Sivaramakrishnan V
Phytother Res; 2020 Dec; 34(12):3148-3167. PubMed ID: 32881214
[TBL] [Abstract][Full Text] [Related]
2. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.
Guo YR; Cao QD; Hong ZS; Tan YY; Chen SD; Jin HJ; Tan KS; Wang DY; Yan Y
Mil Med Res; 2020 Mar; 7(1):11. PubMed ID: 32169119
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.
Wiersinga WJ; Rhodes A; Cheng AC; Peacock SJ; Prescott HC
JAMA; 2020 Aug; 324(8):782-793. PubMed ID: 32648899
[TBL] [Abstract][Full Text] [Related]
4. Natural Products Against COVID-19 Inflammation: A Mini-Review.
Lopes SM; de Medeiros HIR; Scotti MT; Scotti L
Comb Chem High Throughput Screen; 2022; 25(14):2358-2369. PubMed ID: 35088662
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial.
Zeng C; Yuan Z; Pan X; Zhang J; Zhu J; Zhou F; Shan Z; Yuan Y; Ye R; Cheng J
Trials; 2020 Dec; 21(1):1029. PubMed ID: 33357239
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of clinical and pathological features between severe acute respiratory syndrome and coronavirus disease 2019].
Zhang T; Sun LX; Feng RE
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Jun; 43(6):496-502. PubMed ID: 32241072
[TBL] [Abstract][Full Text] [Related]
7. A Comprehensive Review of Manifestations of Novel Coronaviruses in the Context of Deadly COVID-19 Global Pandemic.
Gulati A; Pomeranz C; Qamar Z; Thomas S; Frisch D; George G; Summer R; DeSimone J; Sundaram B
Am J Med Sci; 2020 Jul; 360(1):5-34. PubMed ID: 32620220
[TBL] [Abstract][Full Text] [Related]
8. COVID-19: a conundrum to decipher.
Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
[TBL] [Abstract][Full Text] [Related]
9. [Biological Product Development Strategies for Prevention and Treatment of Coronavirus Disease 2019].
Yan CX; Li J; Shen X; Luo L; Li Y; Li MY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Mar; 51(2):139-145. PubMed ID: 32220178
[TBL] [Abstract][Full Text] [Related]
10. The novel zoonotic COVID-19 pandemic: An expected global health concern.
Contini C; Di Nuzzo M; Barp N; Bonazza A; De Giorgio R; Tognon M; Rubino S
J Infect Dev Ctries; 2020 Mar; 14(3):254-264. PubMed ID: 32235085
[TBL] [Abstract][Full Text] [Related]
11. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
12. Target-Specific Drug Discovery of Natural Products against SARS-CoV-2 Life Cycle and Cytokine Storm in COVID-19.
Lee M; Park J; Cho IH
Am J Chin Med; 2022; 50(4):927-959. PubMed ID: 35729089
[TBL] [Abstract][Full Text] [Related]
13. Targeting Natural Products for the Treatment of COVID-19 - An Updated Review.
Pamuru RR; Ponneri N; Damu AG; Vadde R
Curr Pharm Des; 2020; 26(41):5278-5285. PubMed ID: 32881659
[TBL] [Abstract][Full Text] [Related]
14. Covid-19: pharmacotherapeutic insights on various curative approaches in terms of vulnerability, comorbidities, and vaccination.
Kaur R; Singh S; Singh TG; Sood P; Robert J
Inflammopharmacology; 2022 Feb; 30(1):1-21. PubMed ID: 34981320
[TBL] [Abstract][Full Text] [Related]
15. Respiratory and ventilator management of COVID-19.
Khan NA; Akhtar J
J Pak Med Assoc; 2020 May; 70(Suppl 3)(5):S60-S63. PubMed ID: 32515384
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic targets of natural products for the management of cardiovascular symptoms of coronavirus disease 2019.
Mohammadi Pour P; Farzaei MH; Soleiman Dehkordi E; Bishayee A; Asgary S
Phytother Res; 2021 Oct; 35(10):5417-5426. PubMed ID: 34110678
[TBL] [Abstract][Full Text] [Related]
17. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
[TBL] [Abstract][Full Text] [Related]
18. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
19. Promising natural products against SARS-CoV-2: Structure, function, and clinical trials.
Zhao Y; Deng S; Bai Y; Guo J; Kai G; Huang X; Jia X
Phytother Res; 2022 Oct; 36(10):3833-3858. PubMed ID: 35932157
[TBL] [Abstract][Full Text] [Related]
20. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.
Lai CC; Shih TP; Ko WC; Tang HJ; Hsueh PR
Int J Antimicrob Agents; 2020 Mar; 55(3):105924. PubMed ID: 32081636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
